Primary Recipient

GALENEA CORPORATION

Amount

$4,484,789.00

Award Date

9/27/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Schizophrenia is a debilitating psychiatric disorder that affects about 0.7% of the global population. Symptoms of schizophrenia can be grouped into three categories: positive symptoms, including hallucinations and delusions; negative symptoms, such as so

Vendors Connected to Award

Vendor	Role	Amount
PerkinElmer Health Sciences	Primary vendor	$59,231.00
Cellectricon, Inc.	Primary vendor	$37,605.00
VWR International Inc.	Primary vendor	$26,768.59